High programmed cell death 1 ligand–1 expression: association with CD8+ T-cell infiltration and poor prognosis in human medulloblastoma

Daiki Murata, Yohei Mineharu, Yoshiki Arakawa, +10

Journal of neurosurgery

Low InfiltrationImmunologyCell DeathPathologyImmunotherapy +19

PD-1/PD-L1 expression in a series of intracranial germinoma and its association with Foxp3+ and CD8+ infiltrating lymphocytes

Bin Liu, Yoshiki Arakawa, Ryuta Yokogawa, +10

PLoS ONE

Fibro-Fatty Volume of Culprit Lesions in Virtual Histology™ Intravascular Ultrasound Is Associated with the Amount of Debris during Carotid Artery Stenting

Shoji Matsumoto, Ichiro NAKAHARA, Toshio Higashi, +7

Cerebrovascular Diseases

Prognostic effect of cachexia in patients with non‐small cell lung cancer receiving immune checkpoint inhibitors

Norikazu Matsuo, Koichi Azuma, Kenta Murotani, +6

Thoracic Cancer

A case of cytokine release syndrome accompanied with <scp>COVID</scp>‐19 infection during treatment with immune checkpoint inhibitors for non‐small cell lung cancer

Daiki Murata, Koichi Azuma, Saeko Tokisawa, +2

Thoracic Cancer

Acute Lung InjuryInflammatory Lung DiseaseAdvanced Lung DiseaseLung InflammationLung Adenocarcinoma +25

High mobility group A1 expression shows negative correlation with recurrence time in patients with glioblastoma multiforme

Bin Liu, Bo Pang, Huajie Liu, +14

Pathology - Research and Practice

Neuro-oncologyGliomaTumor HeterogeneityRecurrence TimeGlioblastoma Multiforme +10

Survival and biomarkers for cachexia in non‐small cell lung cancer receiving immune checkpoint inhibitors

Daiki Murata, Koichi Azuma, Norikazu Matsuo, +6

Cancer Medicine

Retrospective Analysis of Bevacizumab in Combination With Ifosfamide, Carboplatin, and Etoposide in Patients With Second Recurrence of Glioblastoma

Yoshiki Arakawa, Takashi Mizowaki, Daiki Murata, +6

Neurologia medico-chirurgica

Clinical significance of interstitial lung abnormalities and immune checkpoint <scp>inhibitor‐induced</scp> interstitial lung disease in patients with <scp>non‐small</scp> cell lung cancer

Daiki Murata, Koichi Azuma, Goushi Matama, +5

Thoracic Cancer

CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma

Yohei Sekino, Kenshiro Takemoto, Daiki Murata, +15

Anticancer Research